Aims Absolute risk reduction (ARR) and number needed to treat (NNT) are considered by
many to be the most appropriate figures to use for the informed consent process, yet the …

Aims Three randomized trials of implantable cardioverter defibrillator (ICD) therapy vs
medical treatment for the prevention of death in survivors of ventricular fibrillation or …

Background We sought to examine the mortality impact of appropriate implantable
cardioverter defibrillator (ICD) therapy between patients who received ICD for primary …

Objective To estimate the baseline risk of arrhythmic death required for prophylactic
implantable cardiac defibrillators (ICDs) to result in clinically meaningful survival benefits in …

Introduction: There are little data on cardiologists' knowledge and application of current
implantable cardioverter defibrillator (ICD) guidelines, attitudes to risk, and how these may …

Background Implantable cardioverter–defibrillators (ICDs) are battery-powered implantable
devices that monitor heart rhythm and deliver therapy in the form of either electric shock or …

Background—Although implantable cardioverter-defibrillators (ICDs) reduce mortality in
primary prevention patients with left ventricular systolic dysfunction, recent studies have …

Background Although randomized trials have shown the beneficial effect on survival of an
implantable cardioverter defibrillator (ICD) as primary prevention therapy in selected …

Background Primary prevention implantable cardioverter defibrillator (ICD) reduce all-cause
mortality by reducing sudden cardiac death. There are conflicting data regarding whether …

Background In at-risk patients with left ventricular dysfunction, implantable cardioverter
defibrillators (ICDs) prolong life. Implantable cardioverter defibrillators are increasingly …